Modulation of the Ca 2+,Mg2+-ATPase of sarcoplasmic reticulum by the hypothalamic hypophyseal inhibitory factor  by Ricoteb, M. et al.
et Biophysics &ta 
ELSEVIER Biochimica et Biophysics Acta 1232 (1995) 217-224 
Modulation of the Ca2+,Mg 2-t -ATPase of sarcoplasmic reticulum by the 
hypothalamic hypophyseal inhibitory factor 
M. Ricote b, E. Garcia-Martin a, J. Sancho b,*, C. Gutikrez-Merino a 
a Departamento de Bioquimica y Biologia Molecular y Gene’tica, Facultad de Ciencias, UEX, 06080 Badajoz. Spain 
’ Seru. Endocrinologia, Hospital ‘Ram& y Cajal, ’ Can-. Colmenar Km. 9. I, 28034 Madrid, Spain 
Received 12 April 1995; revised 7 August 1995; accepted 25 August 1995 
Abstract 
We have studied the effect of the endogenous inhibitor of the Na+ and Ca*+ pumps, HHIF, on sarcoplasmic reticulum (SR) vesicles. 
The effect of HHIF on the SR Ca2+,Mg 2f-ATPase activity shows a biphasic pattern. Low HHIF concentrations activate the 
Ca’+,Mg 2+-ATPase by dissip ation of Ca2+ gradient across the SR membrane. Higher concentrations irreversibly inhibit this activity 
following a slow kinetic process both in intact SR membranes and in purified Ca *+,Mg*+-ATPase. Differential scanning calorimetry 
shows that the Ca2+,Mg2’ -ATPase is denatured after incubation with HHIF concentrations which produced full inhibition of its activity. 
Micromolar Ca2+ and millimolar Mg 2+ADP protect against the irreversible inhibition of the Ca’+,Mg*+-ATPase by HHIF. The 
concentration of HHIF which produces 50% inhibition depends upon SR membrane concentration and upon the 1ipid:protein ratio in 
purified Ca 2+,Mg2’-ATPase. From this we have obtained a partition coefficient for binding of HHIF to SR membranes of 0.6 (pg SR 
protein/ml)- ’ 
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1. Introduction 
In essential hypertension, functional defects in Ca*+ 
handling by vascular smooth muscle cells have been pro- 
posed to be an etiologically important factor and may 
represent a major manifestation of a more generalized 
membrane defect [ 1,2]. Actually, there is growing evidence 
that the alteration of cell Cazf metabolism seen in hyper- 
tension is due to a humoral defect [3,4]. An endogenous 
inhibitor of both Na+ and Ca2+ pumps would thus play an 
important role in the homeostasis of intracellular Ca*+. 
The existence of an endogenous substance that inhibits the 
Abbreviations: Ca’+-ATPase, Ca2+,Mg2+-ATPase; DPH, 1.6.di- 
phenyl- 1,3,5-hexatriene; EGTA, ethylene glycol bis(B-aminoethyl ether)- 
N, N, N’. N’ketraacetic acid; HHIP, hypothalamic hypophyseal inhibitory 
factor: IU, pmol product per min per mg protein; SR, sarcoplasmic 
reticulum; Tes, 2((2-hydroxy-l,l-bisfhydroxymethyl) ethylkuninolethane- 
sulfonic acid. 
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Na+ pump and increases Ca2’ intracellular levels has 
been proposed [5-71. In addition, alterations in the activity 
of Ca2+ channels and in Ca2+ uptake by plasma mem- 
brane and sarcoplasmic reticulum (SR) of vascular smooth 
muscle, leading to increased cytosolic free Ca2+ concen- 
tration, have been noted [2,8,9]. A dysfunctioning of the 
CazC pump ATPase in the sarcoplasmic reticulum in 
vascular smooth muscle has been proposed as a contribut- 
ing factor for the development of genetic hypertension [9]. 
We have purified to homogeneity from bovine hypo- 
thalamus and hypophysis a low-molecular-weight, non- 
peptidic, non-lipidic Na+,K+-ATPase inhibitor factor that 
is different from any other known Na+ pump inhibitor. 
This factor has been called hypothalamic hypophyseal 
inhibitory factor (HHIF) [lO,ll]. We have reported that 
HHIF also inhibits Ca2+,Mgzf-ATPase activity and Ca2+ 
uptake of the plasma membrane of synaptosomes [12] and 
raises the intrasynaptosomal concentration of Ca2+ (un- 
published results), and increases cell proliferation of rat 
mesangial cells in culture [13]. Recently, Rodriguez- 
Barber0 et al. [14] have shown that HHIF -nduced prolifer- 
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ation and contraction of primary cultures of rat mesangial 
cells is inhibited by endoplasmic reticulum Ca’+ release 
blocker TMB-8. This suggests that HHIF might also act as 
a modulator of Ca*+-transport systems of intracellular 
stores, such as endoplasmic and sarcoplasmic reticulum, 
since it is a highly hydrophobic compound [IO- 121 and 
also because the increase of cytosolic Ca” induced by 
HHIF in rat mesangial cells in culture shows a lag-phase 
of several minutes, particularly at low HHIF concentra- 
tions [l4]. In particular, inhibition by HHIF of the endo- 
plasmic reticulum Ca’+-pump could account for the ob- 
served increase of contraction of rat mesangial cells. The 
Ca’+-pump of endoplasmic reticulum is a P-ATPase closely 
related to the Ca2+-pump of the skeletal muscle SR [ 151. 
Because the SR Ca*+ pump from skeletal muscle repre- 
sents about 80-90% of the total protein of the SR mem- 
brane [ 161, we have studied the effect of HHIF on the SR 
Ca’+-ATPase as a model system, aiming to obtain direct 
experimental evidences for the proposed modulation of 
Ca’+-pumps of intracellular stores by HHIF. 
2. Materials and methods 
SR membranes were purified from rabbit (New Zealand 
White) hind leg muscle as indicated elsewhere [17]. Ca2+- 
ATPase was purified from SR membranes following the 
MacLennan procedure [ 181. Protein concentration was 
measured according to Lowry et al. [ 191, using bovine 
serum albumin as standard. The phospholipid content of 
purified ATPase was measured by phosphorus analysis as 
inorganic phosphate [20], and was found to range between 
35 and 45 mol phospholipid per mol of ATPase, in good 
agreement with earlier reports [ l8,2 11. 
Lipid reconstitutions were carried out as described by 
East and Lee [22]. Phosphatidylcholine was dried onto the 
sides of glass tubes, and then dispersed into 0.5 mg 
deoxycholate per mg phospholipid and purified ATPase. 
The mixture was gently vortexed for 30 min and buffer 
was added (50 mM Tes (pH 7.4), 0.5 M sucrose and 0.1 M 
KC]) to give a molar ratio of phospholipid:ATPase of 
300: 1. 
HHIF was purified from bovine hypothalamus and hy- 
pophysis as previously indicated [lo-121. The inhibition 
by HHIF of the Na+,K+-ATPase activity from porcine 
kidney outer medulla was measured using a coupled assay 
and one unit (U) was defined as the amount of HHIF 
required to inhibit by 50% the activity of 8 pg of purified 
Na+,K+-ATPase. 
The Cal+-ATPase activity was measured by using the 
coupled enzyme system [23] with the following assay 
mixture: 0.1 M Tes (pH 7.451, 0.1 M KC], 0.1 mM CaCl,, 
5 mM MgCl,, 2.5 mM ATP, 0.25 mM NADH, 0.42 mM 
phosphoenolpyruvate, 50 pg of pyruvate kinase, 50 pug of 
lactate dehydrogenase. The Ca*+-independent ATPase ac- 
tivity was measured in the presence of 3.4 mM EGTA, and 
only SR membrane preparations showing a value of this 
activity lower than 10% of total uncoupled Ca*+-ATPase 
activity were used in this study. Leakiness of SR vesicles 
was assessed by measuring the Ca2+-ATPase activity in 
the absence and in the presence of calcimycin (4% w/w>. 
Only those preparations showing a 3-4-fold stimulation of 
the Ca’+-ATPase activity at 20-22°C on the addition of 
calcimycin have been used in this study. The specific 
activity of purified Ca2+-ATPase ranged typically between 
5 and 7 IU at 25°C. Each data point in the figures is the 
mean activity of at least duplicate determinations from 
three different experiments (n 2 61, * S.D. 
Calcium uptake was measured using arsenazo III [24,25] 
from the difference in absorbance between 650 and 700 
nm. The conversion of absorbance change into Ca*+ con- 
centration change was carried out upon calibration with 
Ca’+-EGTA solutions, taking a dissociation constant of the 
Ca’+-EGTA complex of IO- ‘.’ at pH 7.4 [26]. The reac- 
tion medium contained 0.1 M Tes (pH 7.4), 0.1 M KCI, 
0.1 mM CaCl?, 5 mM MgCl 2, 2.5 mM ATP and 0.2 mg 
of SR protein/ml. Calcium release has been measured as 
indicated in the legend of Fig. 8, using “Ca’+ (40000- 
50 000 dpm/nmol) and Millipore filtration through 
HAWP-025000 filters, which were counted as indicated in 
[ 121. Aliquots of 50- 100 pg of SR protein were taken for 
filtration in each data point, which was done by triplicate. 
Fluorescence polarization measurements were per- 
formed at 25°C with a Perkin-Elmer mod. 650-40 spectro- 
fluorimeter operated in ratio mode and under magnetic 
stirring. Diphenylhexatriene (DPH) was added to SR mem- 
branes at a DPH/lipid molar ratio lower than l/500. DPH 
fluorescence measurements were done with excitation and 
emission wavelengths of 360 and 440 nm, respectively, 
and after 90 min incubation in darkness to ensure a 
complete incorporation of the probe in the membrane as 
previously described [23]. The steady-state anisotropy of 
the fluorescence of DPH was calculated from polarization 
measurements as indicated in [23,27]. 
Scanning calorimetry measurements were carried out 
with a differential scanning calorimeter MicroCal MC-2, 
operated at a scanning rate of 60 Co/h and under a 
nitrogen pressure of 1.5-2 kg/cm’ during the scan. The 
samples were degassed before loading the calorimeter and 
a time of 30 min was set for equilibration before starting 
the scan. The analysis of the calorimetric data was carried 
out with the OriginTM software developed by MicroCal for 
the MC-2 differential scanning calorimeter. 
2. I. Chemicals 
ADP, ATP, calcimycin, PK (200 IU), LDH (550 IU), 
NADH and phosphoenolpyruvate were obtained from 
Boehringer Mannheim. 45Ca2+ was purchased from Du 
Pont NEN Research Products. All the other chemicals used 
in this study were obtained from Sigma. 
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Fig. I. SR Ca’+-ATPase activity in the presence of HHIF as a function of 
the incubation time. SR vesicles made leaky to Ca’+ by addition of 0.04 
mg calcimycin/mg protein (01, purified Ca’+-ATPase (0) and reconsti- 
tuted Ca’+-ATPase (A). After incubation with HHIF in 0. I M Tes/Tris 
buffer (pH 7.4) during the times indicated in the abscissae, the Ca’+- 
ATPase activity was measured in the assay medium indicated in Materi- 
als and methods. Leaky SR vesicles, purified Ca’+-ATPase and reconsti- 
tuted Ca’+-ATPase were incubated with HHIF at the following 
HHIF/protein ratios (U of HHIF/ pg of protein) 0.31, 0.375 and 1.38, 
respectively. The protein and HHIF concentrations in the assay medium 
were as follows: 4 pg protein per ml (leaky SR vesicles) and 2 pg 
protein per ml (for the case of purified and reconstituted Ca’+-ATPase), 
and the HHIF concentrations were I .25 U/ml for leaky SR vesicles, 0.75 
U/ml for purified Ca”-ATPase and 2.75 U/ml for reconstituted Ca’+- 
ATPase. The reference (100%) is the ATPase activity measured in the 
absence of HHIF for every experimental condition, 3.0 f 0.5 IU for leaky 
SR vesicles and 6 +_ I IU for purified and reconstituted Ca’+-ATPase. 
3. Results 
3.1. Inhibition of the SR Cu2 +-ATPase by HHIF 
HHIF inhibits the Cazf-ATPase activity, the extent of 
inhibition being dependent on the time of incubation with 
HHIF in 0.1 M Tes/Tris buffer at pH 7.4 (Fig. 1). The 
inhibition by HHIF was halted at the times indicated in 
Fig. 1 by dilution of aliquots taken from the incubation 
medium into the assay medium, owing to the protection 
against HHIF-induced inactivation provided by 0.1 mM 
Ca*+ and 2.5 mM Mg2+ -ATP (see below). In the assay 
medium used for Ca’+-ATPase activity measurements, the 
half-time of the HHIF-induced inactivation of leaky SR 
vesicles and of purified and reconstituted Ca*+-ATPase 
determined from the slow decay of the ATPase activity 
with 2 pug protein/ml and 1.5-2.5 U/ml of HHIF was 
found to be higher than 30 min. In all cases, control 
experiments carried out with leaky SR vesicles and with 
purified and reconstituted Ca*+-ATPase in 0.1 M Tes/Tris 
(pH 7.4) at 25°C at a concentration of 2 pg protein/ml in 
the absence of HHIF showed a negligible ( < 10%) loss of 
activity after 20 min incubation. 
Fig. 2 shows that at a fixed time of incubation of 5 min 
with HHIF in 0.1 M Tes/Tris buffer (pH 7.4) at 25°C the 
extent of inhibition of reconstituted Ca2+-ATPase is 
markedly lower than that of purified Ca’+-ATPase. The 
values of the apparent K,, with the same protein concen- 
tration in the assay medium (2 pg/ml) are 1 and 2.75 
U/ml for purified and reconstituted Ca2+-ATPase, respec- 
tively. In the presence of HHIF concentrations close to the 
K o.5 values obtained from Fig. 2, the half-time of the 
HHIF-induced inactivation upon incubation in 0.1 M 
Tes/Tris (pH 7.4) are 2.5 and 5.5 min for SR membranes 
and reconstituted Ca*+-ATPase, respectively (Fig. 1 I. Since 
HHIF is a lipophilic compound [lo- 121 and the lipid/pro- 
tein molar ratio of reconstituted Ca2+-ATPase (300: 1) is 
higher than in purified Ca’+-ATPase (= 45/l), we con- 
sidered the simple hypothesis that its relative efficiency as 
inhibitor of the Ca’+-ATPase could be modulated by the 
lipid bilayer through partition of HHIF in the membrane 
phase. Thus, we studied whether the inhibition produced 
by HHIF was also dependent on the SR membrane or 
Ca’+-ATPase concentrations in the assay medium. 
As depicted in Fig. 3A, at a fixed time of incubation the 
concentration of HHIF that produced 50% inhibition of the 
Ca’+-ATPase of leaky SR vesicles induced by HHIF was 
shifted to higher values when the membrane concentration 
rose. The titrations of the Ca*+-ATPase activity of SR 
membranes with HHIF were carried out in the presence of 
the Ca’+-ionophore calcimycin, to avoid the large inhibi- 
tion produced by luminal Ca’+ [28] which could mask the 
effect of HHIF. The inhibition of purified Ca’+-ATPase is 
also dependent on protein concentration (Fig. 3B). From 
the dependence of K,, versus membrane concentration, 
the apparent partition coefficient (K,) for binding of this 
factor to SR membranes can be calculated according to the 
method of De Foresta et al. [29]. We obtain a K, value of 
0.6 ( pg SR protein/ml)- ’ or (g- 10) IO” (mol lipid/l)- ’ , 
considering that the Ca2+-ATPase amounts to approxi- 
mately 80% of SR membrane protein and that there is 
-0 1 
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Fig. 2. Dependence of the Ca’+-ATPase activity upon the concentration 
of HHIF. Purified Ca’+-ATPase (0) and Ca’+-ATPase reconstituted 
with egg phosphatidylcholine at a molar ratio of phospholipid:ATPase of 
300: I (0). Purified and reconstituted ATPase were incubated in 0. I M 
Tes/Tris (pH 7.4) in the absence and in the presence of HHIF for 5 min 
at 25°C before measuring the Ca 2+-ATPase activity. The protein concen- 
tration in the assay medium was 2 Kg/ml and HHIF concentrations are 
given in the abscissae. The reference (100%) is the ATPase activity 
measured in the absence of HHIF (6 f I IU). 
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Fig. 5. Protection by Mg’+ -ADP and Ca’+ against inactivation by HHIF of the Ca’+-ATPase activity of leaky SR membranes. (Al Effect of Mg’+-ADP 
on the inhibition of the Ca2+ -ATPase activity by HHIF. Leaky SR vesicles were incubated with HHIF (0.31 U of HHIF/Fg of SR protein) in 0.1 M 
Tes/Tris (pH 7.4) (0). 2.5 mh4 Mg’+-ADP (A) or 2.5 mh4 Mg’+-ADP/l mM EGTA (A). (B) Effect of Ca” on the inhibition of the Ca*+-ATPase 
activity by HHIF. Leaky SR vesicles were incubated with HHIF (0.3 1 U of HHIF/pg of SR protein) in 0.1 M Tes/Tris (pH 7.4) plus 10 PM Ca2+ (01, 
0.2 mM CaCl, (0 ) or 1 mM EGTA ( W 1. After the times indicated on the abscissae of (A) and (BI, the Ca2+-ATPase activity was measured in the assay 
medium given in Materials and methods. The concentrations of SR and HHIF in the assay medium were 4 pg/ml and 1.25 U/ml, respectively. 
with Mg’+-ATP instead of Mg”-ADP (data not shown). 
Furthermore, we have studied the effect of Ca*+ in the 
preincubation medium on the inactivation of the Ca*‘- 
ATPase of SR vesicles by HHIF. Free Ca’+ concentrations 
were adjusted using Ca*+-EGTA buffers, with an apparent 
K, for the Ca*+-EGTA complex of lo-‘.’ M at pH 7.4 
[26]. Fig. 5B shows that 0.2 mM CazC largely protects 
against the inhibition by HHIF, as it increases more than 
60-fold the half-time of inactivation observed in the pres- 
ence of EGTA. However, it should be noted that 10 PM 
Ca*+, which saturates the Ca*+ transport sites of the 
Cazf-ATPase at this pH in the absence of HHIF [32], 
affords only a partial protection against inactivation by 
HHIF, e.g., it increases approx. 6-fold the half-time of 
inactivation. Similar results have been obtained using puri- 
fied Ca2+-ATPase (Fig. 6a). The Ca*+ concentration de- 
pendence of the protection by Ca*+ against HHIF inhibi- 
tion of the activity of purified Ca’+-ATPase is shown in 
the Fig. 6B. 5 min incubation of purified Ca*+-ATPase at 
25°C in 0.1 M Tes/Tris (pH 7.4) were taken because in 
the absence of HHIF (control) there is no appreciable loss 
of activity. From Fig. 6b we obtain an apparent K,,, of 
protection by Ca*+ of 5 f 1 /.LM (Fig. 6b), which is only 
3- to 4-fold higher than the K,, of activation of the 
Ca’+-ATPase by Ca’+ obtained under these experimental 
conditions in the absence of HHIF (Fig. 6b; see also [28]). 
These results indicate that the protection afforded by Ca’+ 
against inactivation by HHIF is probably due to Ca’+ 
binding to the high-affinity Ca2+ sites of the Ca2+-ATPase, 
as has been shown to be the case for the protection 
afforded by Ca*+ against denaturation of delipidated and 
solubilized Ca*+-ATPase [3 I]. 
3.3. HHIF produced leakiness to Ca’ + of SR vesicles at 
concentrations lower than those effectively inhibiting the 
Ca2 ‘-ATPase 
As shown in Fig. 7, the dependence of the Ca2+-ATPase 
activity of sealed SR vesicles on the concentration of 
HHIF is complex, with two distinct phases, showing stimu- 
lation of the Ca2+-ATPase activity at low HHIF concentra- 
tions followed by an abrupt inhibition at higher HHIF 
concentrations (apparent Hill coefficient 13 + 2). How- 
(b) 
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Fig. 6. Protection by Ca2+ against inactivation by HHIF of purified 
Ca”-ATPase. (a) Effect of Ca2+ on the kinetics of inhibition of the 
Ca’+-ATPase activity by HHIF. Purified Ca2+-ATPase was incubated at 
25°C with HHIF (0.38 U of HHIF/ Kg of SR protein) in 0.1 M Tes/Tris 
(pH 7.4) plus 10 PM Ca” (01, 0.2 mM CaC12 (0) or 1 mM EGTA 
( ??). After the times indicated on the abscissae the Ca’+-ATPase activity 
was measured in the assay medium given in Materials and methods. The 
concentrations of purified Ca’+-ATPase and of HHIF in the assay 
medium were 4 pg/ml and 1.5 U/ml, respectively. (b) Activity of 
purified Ca’+-ATPase (4 kg/ml) remaining after 5 min incubation at 
25°C with HHIF (0.375 U/pg protein) as a function of the free Ca’* 
concentration in the incubation medium (filled circles). The Ca2+-ATPase 
activity was measured in the assay medium given in Materials and 
methods with a saturating Ca’+ concentration (30 FM). Empty circles, 
Ca2+ dependence of the ATPase activity of the purified Ca’+-ATPase 
without HHIF at pH 7.4 and 25°C. The standard deviation of the data is 
< 10%. 
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Fig. 7. Dependence of the Cal’-ATPase activity upon the concentration 
of HHIF. Sealed SR vesicles (A) and SR vesicles made leaky to Ca’+ 
with calcimycin (0.04 mg/mg protein) (0). SR were incubated in 0. I M 
Tes/Tris (pH 7.4) in the absence and in the presence of HHIF for 5 min 
at 25°C before measuring the Ca’+-ATPase activity. The concentration of 
SR protein in the assay mixture was 4 Kg/ml and HHIF concentrations 
are given in the abscissae. The reference (lOO%) is the ATPase activity 
measured in the absence of HHIF and in the presence of calcimycin 
(3.050.5 III). The standard deviation of the data is < 10%. 
agreement with the values reported by other laboratories 
[33,34]. The HHIF-induced increase of the permeability to 
Ca” of the SR membrane does not appear to require 
preincubation of SR membranes with HHIF, at difference 
to the HHIF-induced inhibition of the Ca’+-ATPase. 
Therefore, these results suggest that the HHIF-induced 
25, -100 
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ever, no stimulation of the Ca’+-ATPase activity is ob- 
served in the presence of the calcium ionophore cal- 
cimycin (4% w/w) and the Ca’+-ATPase activity of sealed 
SR membranes at maximal stimulation by HHIF ap- 
proaches that of SR membranes in the presence of cal- 
cimycin, suggesting that stimulation by HHIF of the 
ATPase activity of sealed SR membranes is due to dissipa- 
tion of the Ca” gradient produced by operation of the 
Ca’+ pump, which largely inhibits the Ca’+-ATPase activ- 
ity [28]. 
The results presented in Fig. 8A demonstrated that the 
steady-state level of Ca’+ accumulation by SR vesicles 
decreases as the concentration of HHIF is increased, be- 
coming negligible at the HHIF concentration which pro- 
duced maximal stimulation of the Ca’+-ATPase activity of 
SR membranes. Because this effect of HHIF could be due 
to uncoupling of the Ca’+ transport from ATP hydrolysis 
in the Cal+-ATPase or alternatively to an increased perme- 
ability to Ca” of SR membranes in the presence of HHIF, 
we studied the permeability of SR membranes to Ca’+ in 
the presence of HHIF. HHIF at concentrations which 
inhibit > 90% of Ca” uptake by SR vesicles, 0.05 U of 
HHIF per pg of SR protein, largely increases the perme- 
ability to Ca’+ of SR membranes (Fig. 8B). This point 
was assessed using two different experimental protocols, 
as indicated in detail in the legend of Fig. 8B. In the 
ATP-loading protocol the SR vesicles were loaded with 
Ca’+ by the activity of the Ca”-pump, under experimen- 
tal conditions identical to those used in Fig. 8A. In parallel 
experiments SR vesicles were passively loaded by incuba- 
tion at pH 7.4 with a buffered solution containing 2 mM 
Cal+. Both experimental approaches gave the same results 
within experimental error. In addition, the half-time for the 
Ca’+ release from SR membranes in the absence of HHIF 
(controls) which we obtained from these results is in good 
J 
Fig. 8. Effect of HHIF on Ca’+ uptake and on Ca’+ release. (A) 
Dependence of Ca’+-uptake and of Ca’+-ATPase activity upon the 
concentration of HHIF. SR membranes (2 mg protein/ml) were incu- 
bated with the indicated concentrations of HHIF for I5 min at 25°C in 0. I 
M Tes/Tris (pH 7.41, and then aliquots were pooled for Ca%tptake and 
Ca’+-ATPase activity measurements. Ca’+-uptake and Ca’+-ATPase 
activity measurements were done at 25°C as indicated in Materials and 
methods. (Bl Ca’+ efflux from SR vesicles in the absence (0.m ) and in 
the presence of HHIF (0.0 1. SR vesicles were loaded with Ca’+ in the 
absence ( ??, 0 ) or in the presence (0.0 1 of ATP as described below. 
ATP-dependent Cc? + loading protocol: SR vesicles (2 mg/ml) were 
loaded with Ca’+ by I min incubation at 25°C with the ATPase assay 
mixture indicated in the Materials and methods section. Ca”-uptake was 
stopped by addition of IO mM glucose/l00 pc~g of hexokinase and 0.3 
mM EGTA. After 30 s, HHIF (100 U/ m was added and this was taken I) 
as the zero time. Aliquots were pooled at the times indicated in the 
abscissae after the addition of HHIF (0). The results obtained in control 
experiments carried out in the absence of HHIF are also presented (0). 
The Ca’+-load of SR membranes 30 s after the addition of the Caz+-stop- 
ping solution (50-55 nmol Ca’+ per mg of SR protein) was taken as the 
100% value for these experimental series. fcrssit,r Cd’ + -louding proto- 
col: SR vesicles (20 mg/ I) m were loaded by 2 h incubation at 25°C with 
a solution containing 50 mM M Tes/O.l M KCl/0.25 M sucrose and 2 
mM CaCI, (pH 7.4). At zero time, the vesicles were diluted up to 2 
mg/ml in a medium containing 50 mM Tes (pH 7.4)/O. I M KCI/ I mM 
EDTA/0.25 M sucrose and I00 U/ml of HHIF (0 ), and aliquots were 
pooled at the times indicated in the abscissae. Control experiments (W ) 
were done by dilution of SR vesicles in the same medium minus HHIF. 
The 100% value for these series were 4-5 nmol Ca’+ per mg of SR 
protein. 
increase of the permeability to CaZi of SR membranes is 
not due to the interaction of HHIF with the Ca’+-ATPase. 
Since HHIF behaves as a lipophilic compound [IO- 121, 
we considered the possibility that the effects of HHIF on 
Ca’+ permeability of SR membranes and/or on the activ- 
ity of the SR Ca”-ATPase could be due, at least in part, 
to large long-range structural perturbations of the lipid 
bilayer. However, HHIF at up to 0.4 U of HHIF per pg of 
SR protein did not solubilize the SR membranes, as indi- 
cated by light-scattering measurements at 400 nm (data not 
shown). The lack of a detergent action of HHIF has been 
noticed elsewhere with synaptosomal membranes [ 121. 
Owing to the modulation of the SR Ca*+-ATPase by the 
long-range organization and dynamic state of the lipid 
bilayer [35,36], we have measured the effect of HHIF on 
the polarization of the fluorescence of the lipid state probe 
DPH incorporated in SR membranes. We have found that 
with up to 0.4 U of HHIF per pg of SR protein (e.g., 10 
U/ml of HHIF and 25 pg/ml of SR protein), the steady- 
state anisotropy of fluorescence of DPH incorporated in 
SR membranes (0.130 f 0.004) is not significantly differ- 
ent from that of control SR membranes (0.136 f 0.0041. 
These results, therefore, exclude the possibility that the 
modulation of the SR Ca”-ATPase activity by HHIF 
arose from a long-range structural perturbation of the lipid 
bilayer, like an altered lipid microviscosity. 
4. Discussion 
Recent results from this laboratory reported elsewhere 
[ 141 suggested a direct action of HHIF on the Ca’+ 
handling by endoplasmic reticulum of rat mesangial cells 
in culture. In this communication, we have investigated the 
effect of the endogenous inhibitor of the plasma membrane 
Naf and Ca2+ pumps, HHIF, on the Ca2+-ATPase activity 
of SR membranes from skeletal muscle. The presence of a 
phenolic ring in HHIF structure has been recently sug- 
gested [ 1 I, 121, and different phenolic compounds are 
known to be potent inhibitors of the Ca*+-ATPase activity 
of SR membranes [37,38] and of Na+,K+-ATPase [39]. 
These compounds have a high tendency to partition into 
the membrane, giving an effect dependent on membrane 
concentration, 
The addition of HHIF produced a biphasic effect on the 
Ca’+-ATPase activity of SR membrane preparations. The 
first phase, observed at low HHIF concentrations, is corre- 
lated with the loss of calcium accumulation by SR vesi- 
cles, which releases the inhibition by high free Ca’+ 
concentrations in the luminal space achieved during active 
transport [28]. Low concentrations of HHIF produced an 
enhanced Ca’+ permeability of SR membranes, which 
accounts for the inhibition of Ca’+ uptake by SR vesicles. 
At higher concentrations, HHIF inhibits the Ca’+-ATPase 
activity of SR membranes. Ca’+ and Mg’+-ADP, which 
shift the ATPase to the El state, protect against inhibition 
by HHIF. 
The concentration dependence of HHIF inhibition and 
activation varies with the concentration of SR membranes 
in the reaction mixture and also with the lipid to protein 
ratio in purified Ca’+-ATPase. This indicated a large 
partitioning of HHIF in the SR membrane. The quenching 
of the intrinsic fluorescence by HHIF (not shown) supports 
this hypothesis, because 1 I out of the 13 Trp of the 
ATPase are located in the intramembranous hydrophobic 
portion of the protein [40]. The partition coefficient of 
HHIF in SR membranes calculated in this paper, 0.6 ( pg 
protein/ml)- ’ . agrees well with the one measured as 
indicated elsewhere for synaptosomal membranes [ 121. 
Because HHIF also has a high tendency for partition on 
liposomes made from lipids extracted from SR mem- 
branes. we concluded that it incorporates into the lipid 
bilayer. However, the inhibition of the Ca”-ATPase is not 
correlated with a significant alteration of the lipid micro- 
viscosity of the SR membrane nor with solubilization of 
the membranes and. thus. the possibility that it could be 
due to a long-range mediated lipid bilayer perturbation can 
be excluded. 
A region of the Ca’+-ATPase where lipophilic 
molecules bind is at the lipid/protein interface [25,37,38, 
411, and it is well established that disruption of the Ca”- 
ATPase lipid annulus, e.g.. delipidation, largely enhances 
the rate of the Ca’+-ATPase irreversible inactivation 
[42.43]. In addition, it has been shown that the lipophilic 
local anaesthetics increase the instability of the Ca’+- 
ATPase in SR membranes by disruption of the lipid annu- 
lus of this membrane protein [23.44]. The very abrupt 
dependence of the Ca”-ATPase inhibition on HHIF con- 
centration (showing apparent Hill coefficients of 13 * 2) 
supports the hypothesis that the inhibition of the Ca”- 
ATPase activity by HHIF is related to the disruption of the 
lipid annulus, because it has been shown that the activity 
of intrinsic membrane proteins shows allosteric behavior 
with respect to the saturation of their annular binding sites 
by lipids [45]. This hypothesis can account for the fact that 
the sensitivity of purified Ca”-ATPase to inhibition by 
HHIF is clearly higher than that of reconstituted Ca’+- 
ATPase with larger lipid to protein ratio, and also that the 
inhibition of the Ca”-ATPase by HHIF is a slow. irre- 
versible process leading to protein unfolding or denatura- 
tion, as shown by the differential scanning calorimetry 
data. In addition, Ca’+ and Mg’+-ADP, which protect 
against thermal denaturation of purified Ca’+-ATPase 
[30,46], are also effective antagonists of the irreversible 
inactivation by HHIF of the Ca’+-ATPase. In the case of 
Ca’+, the Ko5 of protection against inactivation by HHIF 
is only 3- to 4-fold higher than the K,,, of Ca’+-ATPase 
activation by Ca- 7c in the absence of HHIF, which is due 
to saturation of the high-affinity Ca’+ sites of the Ca”- 
ATPase [16,28,31]. A decreased affinity for Ca’+ binding 
to the high-affinity sites of the Cal+-ATPase has been 
reported in the presence of other lipophilic compounds, 
such as pentobarbital [25]. procaine [47]. thapsigargin and 
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2,5-di( tert-butyl)- 1 ,Cbenzohydroquinone [48] or deter- 
gents like Triton X-100 below its critical micelle concen- 
tration [49]. Therefore, these results suggest that the pro- 
tection afforded by Ca2+ against the irreversible inactiva- 
tion produced by HHIF can be accounted for binding of 
Cal+ to the high-affinity sites of the Ca*+-ATPase, as has 
been suggested previously for Ca*+ protection against the 
thermal denaturation of solubilized and delipidated Ca’+- 
ATPase [46] and of the Ca’+-pump of SR membranes [.50]. 
In conclusion, at low concentrations HHIF stimulates 
Ca’+ release from SR vesicles and at higher concentra- 
tions produces irreversible inactivation by denaturation of 
the Ca2+-ATPase of SR membranes. Therefore, interaction 
of HHIF with SR membranes largely decreases the ability 
of these membranes to store and sequester Ca’+, and could 
account for the increased cytosolic Ca*+ and contractility 
reported for muscle cells in culture upon incubation with 
HHIF [14]. 
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